Pharmacotherapy of insomnia in patients with occupational chronic mercury intoxication

Author:

Korchuganova E. H.1ORCID,Katamanova E. V.1ORCID,Slivnitsyna N. V.1ORCID

Affiliation:

1. East-Siberian Institute of Medical and Ecological Research

Abstract

Introduction. Among occupational poisoning, chronic mercury intoxication (CMI) in the Irkutsk region occupies a leading position. Objective. To give a comparative analysis of the methods of pharmacotherapy of sleep disorders in patients in the long-term CRI. Material and methods. The study included 60 patients with long-term CRI, divided into two equal groups of 30 cases: in the first, the average age was 56.0 ± 0.7, in the second, the average age was 57.1 ± 3.0. Questionnaires were conducted using the hospital scale of anxiety and depression, electroencephalographic, polysomnographic studies before and after treatment. During the study, two treatment regimens for sleep disorders were implemented: the first regimen included the administration of an antidepressant (trazodone) and the chemical analog of melatonin (melaxen), and the second regimen was zolpidem. Statistical processing of the research results was carried out using the software package “Statistica 6.0”. Results. After treatment, in the first group there was an increase in the duration of the total sleep time (p = 0.0008), a decrease in the time of falling asleep (p = 0.004), a decrease in the total number of activations (p = 0.00005), and the time of wakefulness in bed (p = 0.0018), an increase in the representation of delta sleep (p = 0.03), and REM sleep (p = 0.004), an increase in the sleep efficiency index (p = 0.0008), and a decrease in the integrative sleep quality index (p = 0.001). In the second group, only a decrease in the latent period of stage 1 (time of falling asleep) was established (p = 0.05). Discussion. After treatment with trazodone in combination with melaxen, a decrease in the severity of presomnic and intrasomnic disorders was found, and in patients taking zolpidem, only the severity of presomnic disorders was reduced. The results confirm the hypothesized cause of dissominal disorders in CRI (changes in the activity of the limbic-reticular complex). Conclusion. The use of trazodone in combination with melaxen proves the improvement of the qualitative and quantitative indices of the structure of night sleep in patients in the long-term postexposure period of CRI.

Publisher

Federal Scientific Center for Hygiene F.F.Erisman

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Pollution,General Medicine

Reference36 articles.

1. Meshchakova N.M., D’yakovich M.P., Shayakhmetov S.F., Lisetskaya L.G. Formation of risks for a health disaster in workers, exposed to mercury. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2018; 97(10): 945–50. https://doi.org/10.18821/0016-9900-2018-97-10-945–50 (in Russian)

2. Olzhaeva R.R., Tapbergenov S.O. Features mechanisms of adaptation and resistance of the organism at mercury intoxication. Fundamental’nye issledovaniya. 2014; (5–4): 772–5. (in Russian)

3. Concise international chemical assessment document 50. Elemental mercury and inorganic mercury compounds: human health aspects. Geneva: WHO; 2003. Available at: http://www.who.int/ipcs/publications/cicad/en/cicad50.pdf

4. Onishchenko G.G. Hygienic problems of population health. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2010; 89(1): 87–90. (in Russian)

5. Shilov V.V., Chashchin V.P., Belikova V.D., Polozova E.V., Konstantinov R.V. Mercury in the Human Body Under Conditions of Environmental Pollution with Mercury-Containing Industrial Waste [Ostrye i khronicheskie otravleniya rtut’yu]. St. Petersburg; 2006. (in Russian)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3